News

Under terms of the arrangement, Johns Hopkins will be available to read diagnostic images for primary care physicians, throughout the greater Baltimore area and surrounding counties, utilizing Digirad

Myriad and Lundbeck have entered into a European commercialization agreement under which Lundbeck will have rights to market and sell Flurizan in the EU and several associated non-EU

This is the company’s fifth approval in the US after earlier approvals for Carboplatin, Paclitaxel, Epirubicin & Irinotecan. Mitoxantrone is an antineoplastic agent used in combination with corticosteroids

Previously cleared for accelerated treatment of early stage breast cancer, the Axxent System, a proprietary technology platform designed to deliver localized, non-radioactive, isotope-free radiation treatment in minimally-shielded clinical

Dr Cohen joins Kosan from GE Healthcare Medical Diagnostics where she served as the global oncology therapeutic area head, responsible for strategic development, clinical trial implementation and registration

In a preclinical study, benign prostatic hyperplasia (BPH) was induced through subcutaneous injection of testosterone propionate. One week prior to initiation of testosterone, either D-3263 or finasteride, a

The sNDA submission is based on results of a multi-center, randomized, double-blind study in 699 adult patients, which demonstrated less procedural pain associated with blood draws or IV

The IRB approved study was registered with the National Institute of Health (NIH) and operated under the guidelines of both the NIH and the Israeli Ministry of Health.

The study results show that – 80% of percutaneous tibial nerve stimulation (PTNS) patients considered themselves cured or improved, while 55% of tolterodine LA patients considered themselves cured